A detailed history of Riverwater Partners LLC transactions in Cybin Inc. stock. As of the latest transaction made, Riverwater Partners LLC holds 20,190 shares of CYBN stock, worth $5,249. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,190
Holding current value
$5,249
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$0.3 - $0.46 $6,057 - $9,287
20,190 New
20,190 $8,000

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $43.2M
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Riverwater Partners LLC Portfolio

Follow Riverwater Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverwater Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverwater Partners LLC with notifications on news.